Circadian Rhythms in Human Adipose
Circadian Regulation of Human Adipose Tissue Metabolism
2 other identifiers
interventional
40
1 country
1
Brief Summary
The goal of this study is to understand the underlying circadian rhythms in subcutaneous adipose tissue of humans with our without continuous feeding and how these are altered in people who have obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2021
CompletedFirst Submitted
Initial submission to the registry
March 17, 2025
CompletedFirst Posted
Study publicly available on registry
March 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
April 14, 2026
April 1, 2026
8.4 years
March 17, 2025
April 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
rhythmicity of circadian clock mRNA in adipose tissue
Genes from RNA-seq analysis will be defined as statistically rhythmic.
24 hour
Study Arms (2)
Normal weight participants
ACTIVE COMPARATORParticipants with obesity
ACTIVE COMPARATORInterventions
Participants will receive 24-hour continuous feeds through an NG tube
Participants will receive 3 boluses of feeding per day at regular meal times through an NG tube to mimic normal meals.
Eligibility Criteria
You may qualify if:
- BMI 20-25 kg/m2 or 30-37 kg/m2
- For participants with obesity a waist-to-hip ratio of ≥0.95 in males and ≥0.90 in females.
- sedentary
- females: non pregnant or breastfeeding
- ability to provide written informed consent and follow study instructions
You may not qualify if:
- History of mediations that impact adipocyte/lipid metabolism
- smoking
- insomnia
- sleep apnea
- sleep medication use
- employment in night or shift work
- extreme chronotypes
- Allergy to lidocaine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mayo Clinic
Rochester, Minnesota, 55901, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 17, 2025
First Posted
March 24, 2025
Study Start
July 1, 2021
Primary Completion (Estimated)
December 1, 2029
Study Completion (Estimated)
December 1, 2030
Last Updated
April 14, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share